Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.07327051 |
2 | modulation by symbiont of host immune response (GO:0052553) | 6.07327051 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.07327051 |
4 | modulation by symbiont of host defense response (GO:0052031) | 6.07327051 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.07327051 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.07327051 |
7 | polyketide metabolic process (GO:0030638) | 5.92724152 |
8 | doxorubicin metabolic process (GO:0044598) | 5.92724152 |
9 | daunorubicin metabolic process (GO:0044597) | 5.92724152 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.42578241 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.25948078 |
12 | oligosaccharide catabolic process (GO:0009313) | 4.99412508 |
13 | macrophage activation involved in immune response (GO:0002281) | 4.95992312 |
14 | neutrophil activation involved in immune response (GO:0002283) | 4.85762083 |
15 | immunoglobulin mediated immune response (GO:0016064) | 4.62642262 |
16 | glycolipid catabolic process (GO:0019377) | 4.56781793 |
17 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.54229685 |
18 | response to peptidoglycan (GO:0032494) | 4.53548183 |
19 | amino sugar catabolic process (GO:0046348) | 4.50205026 |
20 | ceramide catabolic process (GO:0046514) | 4.17084376 |
21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.06719946 |
22 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.02962571 |
23 | cytidine deamination (GO:0009972) | 4.02865617 |
24 | cytidine metabolic process (GO:0046087) | 4.02865617 |
25 | cytidine catabolic process (GO:0006216) | 4.02865617 |
26 | positive regulation of interferon-alpha production (GO:0032727) | 3.97146226 |
27 | apoptotic cell clearance (GO:0043277) | 3.92139276 |
28 | microglial cell activation (GO:0001774) | 3.89728926 |
29 | respiratory burst (GO:0045730) | 3.78526724 |
30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.77208374 |
31 | response to host immune response (GO:0052572) | 3.77208374 |
32 | sphingolipid catabolic process (GO:0030149) | 3.72231651 |
33 | regulation of interferon-alpha production (GO:0032647) | 3.72178258 |
34 | membrane lipid catabolic process (GO:0046466) | 3.71371826 |
35 | pinocytosis (GO:0006907) | 3.66781260 |
36 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.58192363 |
37 | phagocytosis, recognition (GO:0006910) | 3.55080057 |
38 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.54341180 |
39 | negative regulation of interleukin-12 production (GO:0032695) | 3.49602637 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48756468 |
41 | reactive oxygen species biosynthetic process (GO:1903409) | 3.48600544 |
42 | macrophage activation (GO:0042116) | 3.46566761 |
43 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.41478078 |
44 | positive regulation of macrophage cytokine production (GO:0060907) | 3.38730016 |
45 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.37161410 |
46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.36344418 |
47 | response to host (GO:0075136) | 3.36344418 |
48 | response to host defenses (GO:0052200) | 3.36344418 |
49 | lysosome organization (GO:0007040) | 3.35890304 |
50 | lytic vacuole organization (GO:0080171) | 3.35890304 |
51 | N-acetylneuraminate metabolic process (GO:0006054) | 3.35314436 |
52 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.34010855 |
53 | negative regulation of phagocytosis (GO:0050765) | 3.33556581 |
54 | B cell mediated immunity (GO:0019724) | 3.33256825 |
55 | barbed-end actin filament capping (GO:0051016) | 3.24351571 |
56 | adhesion of symbiont to host cell (GO:0044650) | 3.22585569 |
57 | virion attachment to host cell (GO:0019062) | 3.22585569 |
58 | myeloid cell activation involved in immune response (GO:0002275) | 3.20145248 |
59 | mannose metabolic process (GO:0006013) | 3.18463497 |
60 | amyloid precursor protein catabolic process (GO:0042987) | 3.16012949 |
61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.14082344 |
62 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.10997375 |
63 | adhesion of symbiont to host (GO:0044406) | 3.09532388 |
64 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07220477 |
65 | response to muramyl dipeptide (GO:0032495) | 3.05275242 |
66 | phagocytosis, engulfment (GO:0006911) | 3.01747351 |
67 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.01308864 |
68 | neutrophil mediated immunity (GO:0002446) | 3.01023503 |
69 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.00040933 |
70 | detection of molecule of bacterial origin (GO:0032490) | 2.99477758 |
71 | granulocyte activation (GO:0036230) | 2.98974675 |
72 | negative regulation of interleukin-6 production (GO:0032715) | 2.97842606 |
73 | glycoside metabolic process (GO:0016137) | 2.97175717 |
74 | regulation of apoptotic cell clearance (GO:2000425) | 2.95886264 |
75 | neutrophil activation (GO:0042119) | 2.93690445 |
76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89604531 |
77 | regulation of antigen processing and presentation (GO:0002577) | 2.89241256 |
78 | positive regulation of bone resorption (GO:0045780) | 2.88944312 |
79 | positive regulation of bone remodeling (GO:0046852) | 2.88944312 |
80 | negative regulation of bone resorption (GO:0045779) | 2.88086836 |
81 | regulation of macrophage cytokine production (GO:0010935) | 2.85153696 |
82 | sphingosine metabolic process (GO:0006670) | 2.84763077 |
83 | interferon-gamma production (GO:0032609) | 2.84170285 |
84 | regulation of mononuclear cell migration (GO:0071675) | 2.83581864 |
85 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.81166778 |
86 | maintenance of protein location in nucleus (GO:0051457) | 2.80616929 |
87 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.77168292 |
88 | regulation of cholesterol storage (GO:0010885) | 2.76229199 |
89 | positive regulation of interferon-beta production (GO:0032728) | 2.74852588 |
90 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.73414652 |
91 | eosinophil chemotaxis (GO:0048245) | 2.72864460 |
92 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70788919 |
93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70788919 |
94 | glycosphingolipid catabolic process (GO:0046479) | 2.70788083 |
95 | * keratan sulfate catabolic process (GO:0042340) | 2.70202256 |
96 | phagosome maturation (GO:0090382) | 2.69878933 |
97 | positive regulation of mast cell activation (GO:0033005) | 2.69589063 |
98 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.69538101 |
99 | peptide catabolic process (GO:0043171) | 2.69163413 |
100 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.68032699 |
101 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.67493566 |
102 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.67185107 |
103 | regulation of macrophage chemotaxis (GO:0010758) | 2.64977688 |
104 | cyclooxygenase pathway (GO:0019371) | 2.64931398 |
105 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.64628143 |
106 | plasma lipoprotein particle clearance (GO:0034381) | 2.63777194 |
107 | endosome to pigment granule transport (GO:0043485) | 2.63574181 |
108 | endosome to melanosome transport (GO:0035646) | 2.63574181 |
109 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.63306432 |
110 | regulation of mast cell degranulation (GO:0043304) | 2.63134759 |
111 | hormone catabolic process (GO:0042447) | 2.63028363 |
112 | regulation of phagocytosis (GO:0050764) | 2.62496014 |
113 | positive regulation of cholesterol efflux (GO:0010875) | 2.61339767 |
114 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59885125 |
115 | negative regulation of granulocyte differentiation (GO:0030853) | 2.59508834 |
116 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.58765258 |
117 | regulation of cholesterol esterification (GO:0010872) | 2.58203806 |
118 | leukocyte mediated cytotoxicity (GO:0001909) | 2.57185632 |
119 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.56642054 |
120 | positive regulation of tissue remodeling (GO:0034105) | 2.56409433 |
121 | natural killer cell mediated immunity (GO:0002228) | 2.55769670 |
122 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.55769670 |
123 | eosinophil migration (GO:0072677) | 2.55062533 |
124 | positive regulation of leukocyte degranulation (GO:0043302) | 2.54765297 |
125 | low-density lipoprotein particle clearance (GO:0034383) | 2.53748224 |
126 | regulation of mast cell activation (GO:0033003) | 2.53709423 |
127 | response to thyroid hormone (GO:0097066) | 2.53492473 |
128 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.52756326 |
129 | negative regulation of interleukin-17 production (GO:0032700) | 2.52188724 |
130 | regulation of chemokine biosynthetic process (GO:0045073) | 2.51926184 |
131 | regulation of superoxide anion generation (GO:0032928) | 2.51594608 |
132 | T-helper 1 type immune response (GO:0042088) | 2.51588926 |
133 | negative regulation of mast cell activation (GO:0033004) | 2.51258455 |
134 | melanin biosynthetic process (GO:0042438) | 2.49807015 |
135 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.49500518 |
136 | muscle organ morphogenesis (GO:0048644) | 2.48240693 |
137 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.48002148 |
138 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.47686555 |
139 | cellular response to arsenic-containing substance (GO:0071243) | 2.47508276 |
140 | diol metabolic process (GO:0034311) | 2.47296535 |
141 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.46343094 |
142 | positive regulation of sterol transport (GO:0032373) | 2.45819895 |
143 | positive regulation of cholesterol transport (GO:0032376) | 2.45819895 |
144 | glucosamine-containing compound catabolic process (GO:1901072) | 2.45719773 |
145 | intracellular pH reduction (GO:0051452) | 2.43003554 |
146 | * glycosphingolipid metabolic process (GO:0006687) | 2.42593170 |
147 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.42556119 |
148 | cholesterol efflux (GO:0033344) | 2.41263462 |
149 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.40215122 |
150 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.39714190 |
151 | pH reduction (GO:0045851) | 2.38390476 |
152 | protein localization to endosome (GO:0036010) | 2.35926075 |
153 | transferrin transport (GO:0033572) | 2.35426316 |
154 | regulation of leukocyte degranulation (GO:0043300) | 2.33665119 |
155 | myeloid dendritic cell differentiation (GO:0043011) | 2.33292037 |
156 | negative regulation of lipid storage (GO:0010888) | 2.32414024 |
157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.31698708 |
158 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.31269499 |
159 | NIK/NF-kappaB signaling (GO:0038061) | 2.30016180 |
160 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.29902379 |
161 | angiotensin maturation (GO:0002003) | 2.26881780 |
162 | low-density lipoprotein particle remodeling (GO:0034374) | 2.26690901 |
163 | Golgi transport vesicle coating (GO:0048200) | 2.25177058 |
164 | COPI coating of Golgi vesicle (GO:0048205) | 2.25177058 |
165 | nitric oxide biosynthetic process (GO:0006809) | 2.25106262 |
166 | monocyte chemotaxis (GO:0002548) | 2.23342486 |
167 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.23111125 |
168 | phospholipid efflux (GO:0033700) | 2.23050935 |
169 | type I interferon signaling pathway (GO:0060337) | 2.23032893 |
170 | cellular response to type I interferon (GO:0071357) | 2.23032893 |
171 | glycosylceramide metabolic process (GO:0006677) | 2.21762788 |
172 | glial cell migration (GO:0008347) | 2.21699177 |
173 | response to type I interferon (GO:0034340) | 2.21452120 |
174 | * hyaluronan catabolic process (GO:0030214) | 2.21320162 |
175 | regulation of extracellular matrix disassembly (GO:0010715) | 2.21151820 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.41681847 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.44071386 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.89425679 |
4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.43239268 |
5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.43239268 |
6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.43239268 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.12804965 |
8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07138937 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71662983 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.68278970 |
11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59913227 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.47743782 |
13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.46401232 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38724126 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.32214449 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14753668 |
17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.06756032 |
18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04237731 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99417094 |
20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.94795733 |
21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.92673398 |
22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92112495 |
23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.87853283 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85354263 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80276383 |
26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78226072 |
27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74453624 |
28 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.69348092 |
29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69222791 |
30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68609481 |
31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65959296 |
32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65906180 |
33 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.65525953 |
34 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.65342997 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65079099 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64564259 |
37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.62322250 |
38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59774428 |
39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59477530 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59015648 |
41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52023697 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51007626 |
43 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50178034 |
44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45871329 |
45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45097562 |
46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44284027 |
47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41820315 |
48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39850214 |
49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38358193 |
50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38005217 |
51 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37465039 |
52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37335806 |
53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35078415 |
54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34302722 |
55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34030913 |
56 | MYC_22102868_ChIP-Seq_BL_Human | 1.33014243 |
57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31757101 |
58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30734490 |
59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30465526 |
60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28822917 |
61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28392818 |
62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27663252 |
63 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26644761 |
64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25404796 |
65 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24851242 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23457138 |
67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22692704 |
68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22169868 |
69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22063150 |
70 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21739848 |
71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20943659 |
72 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.20526891 |
73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19270974 |
74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18422654 |
75 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.17972314 |
76 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.17962909 |
77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16795765 |
78 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15680891 |
79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15212337 |
80 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13849447 |
81 | MAF_26560356_Chip-Seq_TH1_Human | 1.13065600 |
82 | MYB_26560356_Chip-Seq_TH2_Human | 1.12971203 |
83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12073338 |
84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10670350 |
85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09530395 |
86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08689616 |
87 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08640733 |
88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08466316 |
89 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07540246 |
90 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07122700 |
91 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06826156 |
92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06665069 |
93 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05938174 |
94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04807489 |
95 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04662290 |
96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04554937 |
97 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.04437693 |
98 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04146536 |
99 | MYB_26560356_Chip-Seq_TH1_Human | 1.03306035 |
100 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.03303826 |
101 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01283955 |
102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99721351 |
103 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99552426 |
104 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98699882 |
105 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98633172 |
106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98451060 |
107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97957304 |
108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97240791 |
109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96677325 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96200185 |
111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95284652 |
112 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94808265 |
113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93668571 |
114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93066939 |
115 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90057774 |
116 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88554385 |
117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87839587 |
118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87789445 |
119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87365402 |
120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85589628 |
121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85563216 |
122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85024880 |
123 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84880598 |
124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.83688204 |
125 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83041626 |
126 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82598293 |
127 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.82246772 |
128 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81826916 |
129 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.81328452 |
130 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80634728 |
131 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76022457 |
132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.75323198 |
133 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.74958987 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.78134577 |
2 | MP0003172_abnormal_lysosome_physiology | 3.67945473 |
3 | MP0006082_CNS_inflammation | 3.64672877 |
4 | MP0001835_abnormal_antigen_presentation | 3.26463705 |
5 | MP0003436_decreased_susceptibility_to | 3.17061686 |
6 | MP0005257_abnormal_intraocular_pressure | 3.10224774 |
7 | MP0002139_abnormal_hepatobiliary_system | 2.89495178 |
8 | MP0003183_abnormal_peptide_metabolism | 2.82147725 |
9 | MP0009840_abnormal_foam_cell | 2.62675523 |
10 | MP0008438_abnormal_cutaneous_collagen | 2.58245735 |
11 | MP0002419_abnormal_innate_immunity | 2.43588115 |
12 | MP0003303_peritoneal_inflammation | 2.42415062 |
13 | MP0002254_reproductive_system_inflammat | 2.39114313 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.36554559 |
15 | MP0003705_abnormal_hypodermis_morpholog | 2.30684923 |
16 | MP0005000_abnormal_immune_tolerance | 2.22547719 |
17 | MP0003806_abnormal_nucleotide_metabolis | 2.19731340 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.11695424 |
19 | MP0000343_altered_response_to | 2.02686332 |
20 | MP0005025_abnormal_response_to | 1.99501269 |
21 | MP0003011_delayed_dark_adaptation | 1.91057539 |
22 | MP0009785_altered_susceptibility_to | 1.90903125 |
23 | MP0004264_abnormal_extraembryonic_tissu | 1.86945289 |
24 | MP0002452_abnormal_antigen_presenting | 1.81465792 |
25 | MP0005387_immune_system_phenotype | 1.81246532 |
26 | MP0001790_abnormal_immune_system | 1.81246532 |
27 | MP0004858_abnormal_nervous_system | 1.79988076 |
28 | MP0001533_abnormal_skeleton_physiology | 1.79407875 |
29 | MP0000372_irregular_coat_pigmentation | 1.73743930 |
30 | MP0003448_altered_tumor_morphology | 1.65245109 |
31 | MP0003566_abnormal_cell_adhesion | 1.58918789 |
32 | MP0002877_abnormal_melanocyte_morpholog | 1.57210944 |
33 | MP0005408_hypopigmentation | 1.55748462 |
34 | MP0002723_abnormal_immune_serum | 1.54283015 |
35 | MP0002405_respiratory_system_inflammati | 1.53421599 |
36 | MP0005171_absent_coat_pigmentation | 1.51441957 |
37 | MP0001800_abnormal_humoral_immune | 1.51106067 |
38 | MP0001819_abnormal_immune_cell | 1.50202002 |
39 | MP0003300_gastrointestinal_ulcer | 1.49927770 |
40 | MP0005310_abnormal_salivary_gland | 1.48794426 |
41 | MP0002420_abnormal_adaptive_immunity | 1.48697337 |
42 | MP0003075_altered_response_to | 1.47840674 |
43 | MP0005365_abnormal_bile_salt | 1.46460547 |
44 | MP0005464_abnormal_platelet_physiology | 1.45561600 |
45 | MP0000685_abnormal_immune_system | 1.45379172 |
46 | MP0000015_abnormal_ear_pigmentation | 1.45130760 |
47 | MP0000858_altered_metastatic_potential | 1.44092633 |
48 | MP0005451_abnormal_body_composition | 1.43366464 |
49 | MP0010352_gastrointestinal_tract_polyps | 1.42881498 |
50 | MP0002998_abnormal_bone_remodeling | 1.40581433 |
51 | MP0005671_abnormal_response_to | 1.38945124 |
52 | MP0005075_abnormal_melanosome_morpholog | 1.37705596 |
53 | MP0003195_calcinosis | 1.37617634 |
54 | MP0003724_increased_susceptibility_to | 1.36270360 |
55 | MP0001845_abnormal_inflammatory_respons | 1.35477556 |
56 | MP0003690_abnormal_glial_cell | 1.32158987 |
57 | MP0000604_amyloidosis | 1.25028584 |
58 | MP0010307_abnormal_tumor_latency | 1.23513157 |
59 | MP0005390_skeleton_phenotype | 1.23410317 |
60 | MP0008469_abnormal_protein_level | 1.22753440 |
61 | MP0002332_abnormal_exercise_endurance | 1.19155998 |
62 | MP0005023_abnormal_wound_healing | 1.18382741 |
63 | MP0005165_increased_susceptibility_to | 1.16722382 |
64 | MP0009333_abnormal_splenocyte_physiolog | 1.16557088 |
65 | MP0004947_skin_inflammation | 1.15426145 |
66 | MP0001853_heart_inflammation | 1.12994640 |
67 | MP0000689_abnormal_spleen_morphology | 1.12504983 |
68 | MP0003329_amyloid_beta_deposits | 1.11850521 |
69 | MP0010386_abnormal_urinary_bladder | 1.11089446 |
70 | MP0002277_abnormal_respiratory_mucosa | 1.10789729 |
71 | MP0000716_abnormal_immune_system | 1.10652222 |
72 | MP0008260_abnormal_autophagy | 1.08834132 |
73 | MP0000490_abnormal_crypts_of | 1.08146808 |
74 | MP0004782_abnormal_surfactant_physiolog | 1.04346405 |
75 | MP0003279_aneurysm | 1.04184737 |
76 | MP0004510_myositis | 1.03055431 |
77 | MP0003828_pulmonary_edema | 1.02899793 |
78 | MP0005164_abnormal_response_to | 1.02818207 |
79 | MP0002429_abnormal_blood_cell | 0.99133493 |
80 | MP0005167_abnormal_blood-brain_barrier | 0.98031399 |
81 | MP0004883_abnormal_blood_vessel | 0.97131812 |
82 | MP0001849_ear_inflammation | 0.96958822 |
83 | MP0002396_abnormal_hematopoietic_system | 0.95867543 |
84 | MP0002722_abnormal_immune_system | 0.94455333 |
85 | MP0000465_gastrointestinal_hemorrhage | 0.93518277 |
86 | * MP0003795_abnormal_bone_structure | 0.92079227 |
87 | MP0009278_abnormal_bone_marrow | 0.91646030 |
88 | MP0000249_abnormal_blood_vessel | 0.91380978 |
89 | MP0000371_diluted_coat_color | 0.90655045 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 0.90359045 |
91 | MP0008004_abnormal_stomach_pH | 0.89339444 |
92 | MP0010155_abnormal_intestine_physiology | 0.89333607 |
93 | MP0002398_abnormal_bone_marrow | 0.89294408 |
94 | MP0010329_abnormal_lipoprotein_level | 0.87687187 |
95 | MP0003186_abnormal_redox_activity | 0.87020743 |
96 | MP0001958_emphysema | 0.86721386 |
97 | MP0002837_dystrophic_cardiac_calcinosis | 0.85307060 |
98 | MP0005360_urolithiasis | 0.83272495 |
99 | MP0009764_decreased_sensitivity_to | 0.83272316 |
100 | * MP0000920_abnormal_myelination | 0.82539032 |
101 | MP0005197_abnormal_uvea_morphology | 0.82416173 |
102 | MP0005166_decreased_susceptibility_to | 0.81374455 |
103 | MP0002295_abnormal_pulmonary_circulatio | 0.81015868 |
104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77992861 |
105 | MP0009643_abnormal_urine_homeostasis | 0.77468841 |
106 | MP0000767_abnormal_smooth_muscle | 0.77156272 |
107 | MP0005174_abnormal_tail_pigmentation | 0.76995938 |
108 | MP0003453_abnormal_keratinocyte_physiol | 0.76893959 |
109 | MP0001756_abnormal_urination | 0.76579692 |
110 | MP0004019_abnormal_vitamin_homeostasis | 0.76203561 |
111 | MP0003091_abnormal_cell_migration | 0.76136395 |
112 | MP0003950_abnormal_plasma_membrane | 0.75878914 |
113 | MP0004272_abnormal_basement_membrane | 0.75819611 |
114 | MP0005595_abnormal_vascular_smooth | 0.74506836 |
115 | MP0001324_abnormal_eye_pigmentation | 0.71616408 |
116 | MP0005319_abnormal_enzyme/_coenzyme | 0.71114354 |
117 | MP0001545_abnormal_hematopoietic_system | 0.70209838 |
118 | MP0005397_hematopoietic_system_phenotyp | 0.70209838 |
119 | MP0002933_joint_inflammation | 0.69570525 |
120 | MP0000678_abnormal_parathyroid_gland | 0.69013999 |
121 | MP0000358_abnormal_cell_content/ | 0.68706649 |
122 | MP0006054_spinal_hemorrhage | 0.66430244 |
123 | MP0000609_abnormal_liver_physiology | 0.66280386 |
124 | MP0005508_abnormal_skeleton_morphology | 0.65600244 |
125 | MP0001542_abnormal_bone_strength | 0.65283106 |
126 | MP0009763_increased_sensitivity_to | 0.63566897 |
127 | * MP0000598_abnormal_liver_morphology | 0.63322506 |
128 | MP0008961_abnormal_basal_metabolism | 0.63263566 |
129 | MP0001851_eye_inflammation | 0.62323942 |
130 | MP0001243_abnormal_dermal_layer | 0.61198481 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vacuolated lymphocytes (HP:0001922) | 5.90034834 |
2 | Increased cerebral lipofuscin (HP:0011813) | 5.83283139 |
3 | Systemic lupus erythematosus (HP:0002725) | 5.19598514 |
4 | Dysostosis multiplex (HP:0000943) | 5.18825648 |
5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.10487204 |
6 | Recurrent abscess formation (HP:0002722) | 4.93824820 |
7 | Mucopolysacchariduria (HP:0008155) | 4.42377222 |
8 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.42377222 |
9 | Eczematoid dermatitis (HP:0000976) | 4.42011741 |
10 | Recurrent bacterial skin infections (HP:0005406) | 4.14303086 |
11 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.12484222 |
12 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.12484222 |
13 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.12484222 |
14 | Abnormality of macrophages (HP:0004311) | 3.91325711 |
15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.83673232 |
16 | * Abnormality of liposaccharide metabolism (HP:0010968) | 3.71405057 |
17 | * Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.71405057 |
18 | * Abnormality of glycolipid metabolism (HP:0010969) | 3.71405057 |
19 | Glomerulonephritis (HP:0000099) | 3.49315345 |
20 | Axonal loss (HP:0003447) | 3.42881540 |
21 | Upper motor neuron abnormality (HP:0002127) | 3.31833980 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.28748438 |
23 | Disinhibition (HP:0000734) | 3.22436157 |
24 | Nuclear cataract (HP:0100018) | 3.18847338 |
25 | Myositis (HP:0100614) | 3.10803318 |
26 | Multiple enchondromatosis (HP:0005701) | 3.08100488 |
27 | Gingivitis (HP:0000230) | 3.02199220 |
28 | Prolonged neonatal jaundice (HP:0006579) | 3.01568744 |
29 | Loss of speech (HP:0002371) | 3.00848744 |
30 | Orchitis (HP:0100796) | 2.97613738 |
31 | Agnosia (HP:0010524) | 2.96266007 |
32 | Neurofibrillary tangles (HP:0002185) | 2.94643391 |
33 | Cervical subluxation (HP:0003308) | 2.93208148 |
34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.88639073 |
35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.78686670 |
36 | Mutism (HP:0002300) | 2.73017356 |
37 | Purpura (HP:0000979) | 2.72798349 |
38 | Peritonitis (HP:0002586) | 2.69731797 |
39 | Bilateral microphthalmos (HP:0007633) | 2.66855263 |
40 | Hand muscle atrophy (HP:0009130) | 2.62870476 |
41 | Abnormality of complement system (HP:0005339) | 2.56407414 |
42 | Cardiomegaly (HP:0001640) | 2.50554352 |
43 | Cerebral aneurysm (HP:0004944) | 2.46570157 |
44 | Vertebral compression fractures (HP:0002953) | 2.45148492 |
45 | Pathologic fracture (HP:0002756) | 2.44122260 |
46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33752931 |
47 | Obstructive lung disease (HP:0006536) | 2.33752931 |
48 | Asymmetric septal hypertrophy (HP:0001670) | 2.30117011 |
49 | Reduced antithrombin III activity (HP:0001976) | 2.28503399 |
50 | Recurrent skin infections (HP:0001581) | 2.26929729 |
51 | Albinism (HP:0001022) | 2.26025570 |
52 | Nasal polyposis (HP:0100582) | 2.25533890 |
53 | J-shaped sella turcica (HP:0002680) | 2.22984070 |
54 | Complement deficiency (HP:0004431) | 2.21575755 |
55 | Mediastinal lymphadenopathy (HP:0100721) | 2.18847836 |
56 | Spinal muscular atrophy (HP:0007269) | 2.17690891 |
57 | Xanthomatosis (HP:0000991) | 2.17377301 |
58 | Cellulitis (HP:0100658) | 2.17316649 |
59 | Neuronal loss in central nervous system (HP:0002529) | 2.17166500 |
60 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.16453511 |
61 | Hypoplasia of the fovea (HP:0007750) | 2.16453511 |
62 | Abnormality of the nasal mucosa (HP:0000433) | 2.16449032 |
63 | Spondylolisthesis (HP:0003302) | 2.15871625 |
64 | Increased serum ferritin (HP:0003281) | 2.15699497 |
65 | Distal upper limb amyotrophy (HP:0007149) | 2.13269861 |
66 | Upper limb amyotrophy (HP:0009129) | 2.13269861 |
67 | Autoimmune thrombocytopenia (HP:0001973) | 2.12998829 |
68 | Increased CSF protein (HP:0002922) | 2.11791238 |
69 | Basal ganglia calcification (HP:0002135) | 2.09332336 |
70 | Cerebral inclusion bodies (HP:0100314) | 2.08808710 |
71 | Skin nodule (HP:0200036) | 2.07365499 |
72 | Mitral stenosis (HP:0001718) | 2.06148122 |
73 | Progressive neurologic deterioration (HP:0002344) | 2.05237248 |
74 | Cheilitis (HP:0100825) | 2.05173425 |
75 | Thoracic kyphosis (HP:0002942) | 2.04071240 |
76 | Periodontitis (HP:0000704) | 2.03479250 |
77 | Myocardial infarction (HP:0001658) | 2.02932714 |
78 | Joint stiffness (HP:0001387) | 2.01015986 |
79 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00132018 |
80 | Retinal atrophy (HP:0001105) | 1.99675979 |
81 | Premature rupture of membranes (HP:0001788) | 1.98815868 |
82 | Hepatosplenomegaly (HP:0001433) | 1.98071239 |
83 | Nephritis (HP:0000123) | 1.97914146 |
84 | Petechiae (HP:0000967) | 1.96443963 |
85 | Testicular atrophy (HP:0000029) | 1.95806523 |
86 | Beaking of vertebral bodies (HP:0004568) | 1.95736601 |
87 | Personality changes (HP:0000751) | 1.95733453 |
88 | Fused cervical vertebrae (HP:0002949) | 1.92830264 |
89 | Amyloidosis (HP:0011034) | 1.91191826 |
90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89655427 |
91 | Vaginal fistula (HP:0004320) | 1.89081795 |
92 | Abnormal cartilage morphology (HP:0002763) | 1.86643202 |
93 | Pulmonary infiltrates (HP:0002113) | 1.86254899 |
94 | Ovoid vertebral bodies (HP:0003300) | 1.85412523 |
95 | Hepatoblastoma (HP:0002884) | 1.85175150 |
96 | Global brain atrophy (HP:0002283) | 1.84402686 |
97 | Recurrent fungal infections (HP:0002841) | 1.84159180 |
98 | Hypokinesia (HP:0002375) | 1.83059057 |
99 | Mesangial abnormality (HP:0001966) | 1.82356797 |
100 | Abnormality of the intrinsic pathway (HP:0010989) | 1.82195846 |
101 | Peripheral demyelination (HP:0011096) | 1.81751180 |
102 | Metaphyseal irregularity (HP:0003025) | 1.81590704 |
103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80535844 |
104 | Osteolytic defects of the hand bones (HP:0009699) | 1.80535844 |
105 | Fasciculations (HP:0002380) | 1.80063649 |
106 | Protrusio acetabuli (HP:0003179) | 1.79691345 |
107 | Abnormality of iron homeostasis (HP:0011031) | 1.79536083 |
108 | Rectal fistula (HP:0100590) | 1.79140228 |
109 | Rectovaginal fistula (HP:0000143) | 1.79140228 |
110 | Abnormality of the lumbar spine (HP:0100712) | 1.78661055 |
111 | Urticaria (HP:0001025) | 1.78573011 |
112 | Abnormality of the pleura (HP:0002103) | 1.77758446 |
113 | Chest pain (HP:0100749) | 1.76796088 |
114 | Abnormality of the fovea (HP:0000493) | 1.76778538 |
115 | Protuberant abdomen (HP:0001538) | 1.76045274 |
116 | Neoplasm of head and neck (HP:0012288) | 1.75589459 |
117 | Esophageal neoplasm (HP:0100751) | 1.75589459 |
118 | Interstitial pulmonary disease (HP:0006530) | 1.75376480 |
119 | * Dementia (HP:0000726) | 1.75347026 |
120 | Ocular albinism (HP:0001107) | 1.74407213 |
121 | Hematochezia (HP:0002573) | 1.72695174 |
122 | Abnormality of the periventricular white matter (HP:0002518) | 1.72232533 |
123 | * Diminished motivation (HP:0000745) | 1.71253654 |
124 | Tetraparesis (HP:0002273) | 1.69488726 |
125 | Stomatitis (HP:0010280) | 1.68926870 |
126 | Polyneuropathy (HP:0001271) | 1.68770448 |
127 | Flared iliac wings (HP:0002869) | 1.68589420 |
128 | Bone cyst (HP:0012062) | 1.65564765 |
129 | Hypoplasia of the odontoid process (HP:0003311) | 1.64432503 |
130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.64133497 |
131 | Conjunctival telangiectasia (HP:0000524) | 1.63655362 |
132 | Optic neuritis (HP:0100653) | 1.63455773 |
133 | Retrobulbar optic neuritis (HP:0100654) | 1.63455773 |
134 | White forelock (HP:0002211) | 1.63302896 |
135 | Progressive visual loss (HP:0000529) | 1.63164184 |
136 | Mucosal telangiectasiae (HP:0100579) | 1.62755426 |
137 | Malnutrition (HP:0004395) | 1.62752986 |
138 | * Apathy (HP:0000741) | 1.62485320 |
139 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.62144229 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 6.00028314 |
2 | CDK12 | 4.35894337 |
3 | TGFBR2 | 4.11834081 |
4 | CSF1R | 3.16291158 |
5 | GRK5 | 2.86527890 |
6 | BLK | 2.79568288 |
7 | GRK6 | 2.70844190 |
8 | KIT | 2.25168697 |
9 | TRIB3 | 2.14262270 |
10 | MATK | 2.08586252 |
11 | PAK4 | 2.06166123 |
12 | RIPK4 | 1.92067759 |
13 | GRK7 | 1.91223424 |
14 | TBK1 | 1.90930368 |
15 | STK10 | 1.89723360 |
16 | MOS | 1.83024675 |
17 | IRAK4 | 1.82776413 |
18 | ADRBK2 | 1.80485718 |
19 | TYK2 | 1.69557575 |
20 | BCKDK | 1.64445735 |
21 | GRK1 | 1.60910820 |
22 | CDC42BPA | 1.57131899 |
23 | IRAK3 | 1.55980944 |
24 | RIPK1 | 1.44897210 |
25 | ACVR1B | 1.41498123 |
26 | PDK2 | 1.40945387 |
27 | SCYL2 | 1.40837990 |
28 | LIMK1 | 1.40772728 |
29 | CSK | 1.40676200 |
30 | TAOK3 | 1.33334226 |
31 | IKBKB | 1.33127628 |
32 | MAP4K1 | 1.31393760 |
33 | PRKG2 | 1.29888018 |
34 | MAP2K3 | 1.29422908 |
35 | MAPK7 | 1.28286864 |
36 | PIM2 | 1.25502988 |
37 | ZAP70 | 1.22211707 |
38 | MAP2K6 | 1.17012887 |
39 | TESK2 | 1.15700729 |
40 | FRK | 1.14093915 |
41 | MAPKAPK3 | 1.09769257 |
42 | PKN2 | 1.07920152 |
43 | NME2 | 1.01969093 |
44 | MYLK | 1.01603037 |
45 | CAMK1D | 1.01446315 |
46 | MAP3K14 | 1.01317443 |
47 | MST1R | 0.99977680 |
48 | HCK | 0.99013174 |
49 | PRKD2 | 0.98130315 |
50 | BMX | 0.96201739 |
51 | CAMKK2 | 0.93649908 |
52 | MAP3K3 | 0.93425791 |
53 | BMPR2 | 0.92102200 |
54 | HIPK2 | 0.90067964 |
55 | TXK | 0.88646634 |
56 | MAP3K1 | 0.87718909 |
57 | PDPK1 | 0.86866360 |
58 | NTRK1 | 0.86117443 |
59 | JAK1 | 0.82918788 |
60 | TTN | 0.82009396 |
61 | PRPF4B | 0.80604848 |
62 | JAK3 | 0.79927832 |
63 | FGFR3 | 0.79873346 |
64 | SYK | 0.78991380 |
65 | ITK | 0.75693845 |
66 | JAK2 | 0.74226380 |
67 | TTK | 0.74092021 |
68 | FER | 0.73964580 |
69 | EPHB1 | 0.72946103 |
70 | CSNK1G3 | 0.72794008 |
71 | LYN | 0.71028974 |
72 | LRRK2 | 0.70754828 |
73 | BTK | 0.70508602 |
74 | PRKCD | 0.70370211 |
75 | FLT3 | 0.69537001 |
76 | CAMK4 | 0.69139957 |
77 | TAOK1 | 0.66383749 |
78 | ABL2 | 0.65683251 |
79 | NEK9 | 0.65389651 |
80 | FES | 0.64689044 |
81 | MAPK11 | 0.64220153 |
82 | MET | 0.63693511 |
83 | LCK | 0.61547232 |
84 | WNK1 | 0.58857652 |
85 | CSNK1A1L | 0.58856469 |
86 | TYRO3 | 0.58832886 |
87 | PDK1 | 0.57062972 |
88 | CDK7 | 0.56750293 |
89 | CDK6 | 0.55854314 |
90 | IKBKE | 0.55667278 |
91 | IGF1R | 0.55601276 |
92 | EPHA2 | 0.55468281 |
93 | RPS6KA4 | 0.55059023 |
94 | IRAK1 | 0.54950158 |
95 | PTK6 | 0.54428708 |
96 | PDGFRA | 0.53582724 |
97 | CHUK | 0.53525237 |
98 | EPHA3 | 0.53289704 |
99 | EGFR | 0.52048995 |
100 | SIK1 | 0.50882720 |
101 | TEC | 0.50621057 |
102 | FGFR4 | 0.49869482 |
103 | MAP3K10 | 0.49701400 |
104 | DAPK3 | 0.48854096 |
105 | KDR | 0.48804098 |
106 | PIM1 | 0.47219304 |
107 | RPS6KA2 | 0.47115948 |
108 | MAP3K2 | 0.45551010 |
109 | ICK | 0.45280259 |
110 | IRAK2 | 0.44860852 |
111 | MARK3 | 0.44327767 |
112 | MAP4K2 | 0.43963648 |
113 | CLK1 | 0.43732437 |
114 | EIF2AK2 | 0.43333257 |
115 | DAPK2 | 0.42827689 |
116 | TESK1 | 0.42462320 |
117 | PINK1 | 0.41592426 |
118 | ARAF | 0.41317086 |
119 | FGR | 0.39393524 |
120 | ABL1 | 0.39202425 |
121 | TGFBR1 | 0.38945275 |
122 | PTK2 | 0.38037134 |
123 | ADRBK1 | 0.36996687 |
124 | MAP3K13 | 0.36277441 |
125 | MAPK12 | 0.36061675 |
126 | TRPM7 | 0.35975029 |
127 | CAMKK1 | 0.33798044 |
128 | MAPKAPK2 | 0.33795350 |
129 | DDR2 | 0.33419996 |
130 | PAK1 | 0.31859958 |
131 | ALK | 0.31384370 |
132 | TAOK2 | 0.29785307 |
133 | MAP3K11 | 0.29507942 |
134 | PIK3CG | 0.28500781 |
135 | EIF2AK3 | 0.28291947 |
136 | GSK3A | 0.25464759 |
137 | INSR | 0.25443256 |
138 | PAK2 | 0.24359916 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.16674722 |
2 | * Lysosome_Homo sapiens_hsa04142 | 4.13421279 |
3 | * Other glycan degradation_Homo sapiens_hsa00511 | 3.49611451 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.40178381 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.76344693 |
6 | * Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.73870384 |
7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.10491383 |
8 | Phagosome_Homo sapiens_hsa04145 | 2.08088174 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.04921872 |
10 | Legionellosis_Homo sapiens_hsa05134 | 2.04903962 |
11 | Tuberculosis_Homo sapiens_hsa05152 | 2.02689964 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01338634 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95600545 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 1.90320114 |
15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86303433 |
16 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.82909608 |
17 | Malaria_Homo sapiens_hsa05144 | 1.82203681 |
18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75274768 |
19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62074452 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.57307730 |
21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51130167 |
22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49637427 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47790709 |
24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47484794 |
25 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.46943427 |
26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46573351 |
27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45387002 |
28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.44685333 |
29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.43295468 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42530550 |
31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42237167 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.38891411 |
33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.38016272 |
34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32588285 |
35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30775098 |
36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18838002 |
37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16119613 |
38 | Salmonella infection_Homo sapiens_hsa05132 | 1.09428868 |
39 | Measles_Homo sapiens_hsa05162 | 1.08474804 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.08314782 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04140771 |
42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03717322 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03447241 |
44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00602612 |
45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98530554 |
46 | Prion diseases_Homo sapiens_hsa05020 | 0.98145321 |
47 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97843495 |
48 | Shigellosis_Homo sapiens_hsa05131 | 0.96817634 |
49 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.96340187 |
50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92431294 |
51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86069260 |
52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85104134 |
53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84808406 |
54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83582603 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83082967 |
56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82867334 |
57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82620131 |
58 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82570780 |
59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80726961 |
60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76171995 |
61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74469435 |
62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74272150 |
63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74050296 |
64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72421935 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.70518753 |
66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70503907 |
67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69421236 |
68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69337363 |
69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69164151 |
70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68574760 |
71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68178852 |
72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67665183 |
73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67524549 |
74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66517456 |
75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65501187 |
76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64821861 |
77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64344450 |
78 | Endocytosis_Homo sapiens_hsa04144 | 0.60115710 |
79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58578526 |
80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57897937 |
81 | Asthma_Homo sapiens_hsa05310 | 0.57852906 |
82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57605965 |
83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57246028 |
84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57245977 |
85 | Hepatitis B_Homo sapiens_hsa05161 | 0.56534720 |
86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56254540 |
87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55162763 |
88 | Hepatitis C_Homo sapiens_hsa05160 | 0.54395639 |
89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54051769 |
90 | Platelet activation_Homo sapiens_hsa04611 | 0.53583985 |
91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53318897 |
92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52779135 |
93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51477304 |
94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48768755 |
95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47375556 |
96 | Bladder cancer_Homo sapiens_hsa05219 | 0.47011007 |
97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46209770 |
98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45462720 |
99 | Peroxisome_Homo sapiens_hsa04146 | 0.43654193 |
100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43540879 |
101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40763508 |
102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40321464 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37689609 |
104 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36931291 |
105 | Focal adhesion_Homo sapiens_hsa04510 | 0.36914207 |
106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36884430 |
107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36528744 |
108 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36239341 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.36110628 |
110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.34832996 |
111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34667907 |
112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33961784 |
113 | ABC transporters_Homo sapiens_hsa02010 | 0.33568251 |
114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33183303 |
115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31453599 |
116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31449956 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31350450 |
118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30680967 |
119 | Mineral absorption_Homo sapiens_hsa04978 | 0.29473028 |
120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29266538 |
121 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28959860 |
122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28907862 |
123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28277503 |
124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24937761 |
125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22905229 |
126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21143499 |
127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18728626 |